quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·72d
PRRelease
ImageneBio Inc. logo
MoonLake Immunotherapeutics logo

ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

IMA· ImageneBio Inc.MLTX· MoonLake Immunotherapeutics
Health Care
Original source

Companies

  • IMA
    ImageneBio Inc.
    Health Care
  • MLTX
    MoonLake Immunotherapeutics
    Health Care

Recent analyst ratings

  • Mar 23MLTXUpdateWolfe Research$24.00
  • Mar 19MLTXUpdateRothschild & Co Redburn$40.00
  • Jan 15MLTXUpdateGoldman$10.00
  • Jan 9MLTXUpdateBTIG Research$24.00
  • Nov 25IMAUpdateWedbush$2.00
  • Nov 3MLTXUpdateH.C. Wainwright$30.00

Related

  • SEC2d
    SEC Form DEFA14A filed by MoonLake Immunotherapeutics
  • SEC2d
    SEC Form DEF 14A filed by MoonLake Immunotherapeutics
  • SEC2d
    SEC Form SCHEDULE 13D filed by ImageneBio Inc.
  • INSIDER3d
    SEC Form 3 filed by new insider Lally Robert B
  • INSIDER7d
    SEC Form 3 filed by new insider Su Wei-Guo
  • INSIDER7d
    SEC Form 4 filed by Bonita David P
  • INSIDER7d
    SEC Form 4 filed by Orbimed Advisors Llc
  • INSIDER7d
    SEC Form 4 filed by Bodenstedt Matthias
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022